Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC | 303,000 | reported | 26 Jan 2026 | tx 5+1,301,750 |
| CymaBay Therapeutics, Inc. | 0 | reported | 22 Mar 2024 | tx 6+454,875−454,875 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Jan 2026 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 303,000 | 0.00 USD | deriv |
| 14 Oct 2025 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 198,750 | 0.00 USD | deriv |
| 18 Aug 2025 | PURCHASE | ALX ONCOLOGY HOLDINGS INC | 75,000 | 0.78 USD | |
| 11 Apr 2025 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 125,000 | 0.00 USD | deriv |
| 21 Jan 2025 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 600,000 | 0.00 USD | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 20,125 | — | |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 360,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 74,750 | — | deriv |
| 24 Jan 2024 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 20,125 | 0.00 USD | |
| 24 Jan 2024 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 74,750 | 0.00 USD | deriv |
| 22 May 2023 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 360,000 | 0.00 USD | deriv |